Elevation of HPV-18 and HPV-16 DNA in the plasma of patients with advanced cervical cancer

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 1, 2011, Pages 163-167

  Jaberipour, Mansooreh ^a   Samsami, Alamtaj ^b   Sahraiian, Farahnaz ^b   Kazerooni, Talieh ^b   Hashemi, Masoomeh ^b   Ghaderi, Abbas ^a,b   Habibagahi, Mojtaba ^a,b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cervical cancer cases; HPV 16 DNA; HPV 18 DNA; Iran; Plasma

Indexed keywords

EID: 79958709472     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bosch FX, de Sanjosé S (2002). Human papillomavirus in cervical cancer. Curr Oncol Rep, 4, 175-83.
2. Broomall EM, Reynolds SM, Jacobson RM (2010). Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus. Postgrad Med, 122, 121-9.
3. Castle PE, Solomon D, Schiffman M, et al (2005). Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. J Natl Cancer Inst, 97, 1066-71.
4. Chaiwongkot A, Pientong C, Ekalaksananan T, et al (2007). Evaluation of primers and PCR performance on HPV DNA screening in normal and low grade abnormal cervical cells. Asian Pac J Cancer Prev, 8, 279-82.
5. Chen AC, Keleher A, Kedda MA, et al (2009). Human papillomavirus DNA detected in peripheral blood samples from healthy Australian male blood donors. J Med Virol, 81, 1792-6.
6. Dong SM, Pai SI, Rha SH, et al (2002). Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma. Cancer Epidemiol Biomarkers Prev, 11, 3-6.
7. Esmaeili M, Bonyadi M, Dastranj A, et al (2008). HPV typing in women with cervical precancerous and cancerous lesions in northwestern Iran. Gynecol Obstet Invest, 66, 68-72.
8. Farjadian S, Asadi E, Doroudchi M, et al (2003). High risk HPV types in southern Iranian patients with cervical cancer. Pathol Oncol Res, 9, 121-5.
9. Franceschi S (2005). The IARC commitment to cancer prevention: the example of papillomavirus and cervical cancer. Recent Results Cancer Res, 166, 277-97.
10. Franceschi S and Clifford GM (2005). Re: a study of the impact of adding HPV types to cervical cancer screening and triage tests. J Natl Cancer Inst, 97, 938-9.
11. Gnanamony M, Peedicayil A, Subhashini J, et al (2010). Detection and quantitation of HPV 16 and 18 in plasma of Indian women with cervical cancer. Gynecol Oncol, 116, 447-51.
12. Ho CM, Yang SS, Chien TY, et al (2005). Detection and quantitation of human papillomavirus type 16, 18 and 52 DNA in the peripheral blood of cervical cancer patients. Gynecol Oncol, 99, 615-21.
13. Kay P, Allan B, Denny L, et al (2005). Detection of HPV 16 and HPV 18 DNA in the blood of patients with cervical cancer. J Med Virol, 75, 435-9.
14. Khan MJ, Castle PE, Lorincz AT, et al (2005). The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst, 97, 1072-9.
15. Kjaer S, Hogdall E, Frederiksen K, et al (2006). The absolute risk of cervical abnormalities in high-risk human papillomaviruspositive, cytologically normal women over a 10-year period. Cancer Res, 66, 10630-6.
16. Ma Z, Liu L, Zhang F, et al (2009). Human papillomavirus type 16 exists in bacteria isolated from cervical cancer biopsies. J Int Med Res, 37, 1065-74.
17. Mortazavi S, Zali M, Raoufi M, et al (2002). The prevalence of human papillomavirus in cervical cancer in Iran. Asian Pac J Cancer Prev, 3, 69-72.
18. Nobre RJ, de Almeida LP, Martins TC (2008). Complete genotyping of mucosal human papillomavirus using a restriction fragment length polymorphism analysis and an original typing algorithm. J Clin Virol, 42, 13-21.
19. Sathish N, Abraham P, Peedicayil A, et al (2004). HPV DNA in plasma of patients with cervical carcinoma. J Clin Virol, 31, 204-9.
20. Sima N, Wang W, Kong D, et al (2008). RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53. Apoptosis, 13, 273-81.
21. Smith JS, Lindsay L, Hoots B, et al (2007). Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer, 121, 621-32.
22. Tsai HJ, Peng YW, Lin LY, et al (2005). An association between human papillomavirus 16/18 deoxyribonucleic acid in peripheral blood with p16 protein expression in neoplastic cervical lesions. Cancer Detect Prev, 29, 537-43.
23. Wei YC, Chou YS, Chu TY (2007). Detection and typing of minimal human papillomavirus DNA in plasma. Int J Gynaecol Obstet, 96, 112-6.
24. Yang HJ, Liu VW, Tsang PC, et al (2004). Quantification of human papillomavirus DNA in the plasma of patients with cervical cancer. Int J Gynecol Cancer, 14, 903-10.